Form 4: Biodesix CDO Reports Routine Share Sale for Tax

Biodesix Chief Development Officer Gary Pestano filed a Form 4 detailing the automatic sale of 23 common shares to cover taxes following the vesting of 69 restricted stock units.

Summary

• Gary Pestano, Chief Development Officer of Biodesix Inc. (BDSX), reported transactions on November 10, 2025.
• Pestano acquired 69 shares of Common Stock upon the vesting of Restricted Stock Units (RSUs).
• Concurrently, 23 shares of Common Stock were automatically sold at $7.62 per share to cover tax obligations related to the RSU vesting.
• Following these transactions, Pestano beneficially owns 7,939 shares of Common Stock directly.
• The reported numbers reflect adjustments due to a one-for-twenty reverse stock split effective September 15, 2025.
• The RSUs vest in sixteen successive quarterly installments from February 8, 2022, contingent on continued service.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction related to equity compensation and tax obligations, which is neutral in sentiment. It does not indicate any significant positive or negative operational or financial developments for the company.

Positives

• The vesting of 69 Restricted Stock Units (RSUs) indicates continued equity compensation for a key executive.
• The transaction is part of a pre-planned Rule 10b5-1 arrangement, suggesting a structured approach to equity management.

Negatives

• A total of 23 common shares were disposed of, reducing the executive's direct beneficial ownership by that amount.
• The sale price of $7.62 per share reflects the market value at the time of the tax-related sale.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The transaction is a routine insider equity compensation event and tax-related sale, unlikely to have a material impact on the company's stock price or long-term value.
• Employees: The vesting of RSUs for a key executive reinforces the company's compensation structure, potentially signaling stability in executive retention.

Next Steps

• Continued vesting of remaining Restricted Stock Units in successive quarterly installments, subject to the reporting person's continued service.

Key Dates

Keywords

Biodesix, BDSX, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Gary Pestano, Chief Development Officer, Equity Compensation, Share Sale, Tax Withholding, Reverse Stock Split